Literature DB >> 7007437

Metabolism of parathyroid hormone by isolated rat Kupffer cells and hepatocytes.

G V Segre, A S Perkins, L A Witters, J t Potts.   

Abstract

Data from several laboratories indicate that hepatic mechanisms may have a distinctive role in the metabolism of intact hormone after secretion, a process that accounts, at least partly, for the heterogeneity of circulating parathyroid hormone. Accordingly, we studied the proteolysis of intact hormone by isolated rat Kupffer cells and hepatocytes. Kupffer cells (10(6) cells/ml) and hepatocytes (10(7) cells/ml) were incubated with unlabeled and (125)I-labeled bovine parathyroid hormone at 37 degrees C for periods ranging up to 2 h. When incubated with Kupffer cells, intact hormone disappeared with a t((1/2)) of 12+/-4 min. Radio-immunoassays using sequence-specific antisera showed that the dominant hormonal fragments recovered in the medium have an apparent molecular weight of approximately 6,000, lack amino-terminal antigenic determinants, and react in assays that specifically recognize determinants in the carboxy-terminal portion of the intact hormone. Amino-terminal fragments also were detected in high concentrations, particularly after short incubation periods. Radioiodinated fragments resulting from incubation of (125)I-labeled bovine parathyroid hormone with Kupffer cells had the same apparent size as fragments derived from the metabolism of unlabeled, intact hormone; when analyzed by Edman degradation, positions 34 and 37 of the intact hormone sequence were the amino-terminal amino acids of these dominant carboxy-terminal fragments. Hepatocytes did not hydrolyze the hormone. Thus, metabolism of parathyroid hormone by Kupffer cells results in the appearance of fragments in the media that are immunochemically indistinguishable from, and chemically identical with, those found in plasma when intact hormone is injected intravenously. This indicates that the proteolysis observed in vitro accurately reflects the metabolism of the hormone in vivo. The detection of amino-terminal fragments in concentrations nearly equal to those of carboxy-terminal fragments indicates that cleavage of intact hormone is, initially, by an endopeptidase(s). Kupffer cells may be a source from which specific protease(s) that hydrolyze parathyroid hormone can be characterized, particularly in terms of enzymic specificity and requirements for inhibition. Detailed analysis of the cellular and molecular events during incubation of parathyroid hormone with these cells may help to clarify the biologic significance of the peripheral metabolism of the hormone.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7007437      PMCID: PMC370586          DOI: 10.1172/JCI110053

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Edman degradation of radioiodinated parathyroid hormone: application to sequence analysis and hormone metabolism in vivo.

Authors:  G V Segre; H D Niall; R T Sauer; J T Potts
Journal:  Biochemistry       Date:  1977-05-31       Impact factor: 3.162

3.  A chick bioassay for parathyroid hormone.

Authors:  J A Parsons; B Reit; C J Robinson
Journal:  Endocrinology       Date:  1973-02       Impact factor: 4.736

4.  A simple and inexpensive membrane "lung" for small organ perfusion.

Authors:  R L Hamilton; M N Berry; M C Williams; E M Severinghaus
Journal:  J Lipid Res       Date:  1974-03       Impact factor: 5.922

5.  Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity.

Authors:  G W Tregear; J Van Rietschoten; E Greene; H T Keutmann; H D Niall; B Reit; J A Parsons; J T Potts
Journal:  Endocrinology       Date:  1973-12       Impact factor: 4.736

6.  Multiple immunoreactive molecular forms of parathyroid hormone in human serum. 1.

Authors:  J M Canterbury; E Reiss
Journal:  Proc Soc Exp Biol Med       Date:  1972-09

7.  Isolation and characterization of the bovine parathyroid isohormones.

Authors:  H T Keutmann; G D Aurbach; B F Dawson; H D Niall; L J Deftos; J T Potts
Journal:  Biochemistry       Date:  1971-07-06       Impact factor: 3.162

8.  A protein sequenator.

Authors:  P Edman; G Begg
Journal:  Eur J Biochem       Date:  1967-03

9.  Metabolism of radioiodinated bovine parathyroid hormone in the rat.

Authors:  B V Segre; P D'Amour; J T Potts
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

10.  The degradation of proparathormone and parathormone by parathyroid and liver cathepsin B.

Authors:  R R MacGregor; J W Hamilton; G N Kent; R E Shofstall; D V Cohn
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

View more
  8 in total

1.  Metabolism of osteocalcin.

Authors:  W Farrugia; R A Melick
Journal:  Calcif Tissue Int       Date:  1986-10       Impact factor: 4.333

Review 2.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

3.  De novo autoimmune hepatitis associated with PTH(1-34) and PTH(1-84) administration for severe osteoporosis in a liver transplant patient.

Authors:  P Anagnostis; Z A Efstathiadou; E Akriviadis; P Hytiroglou; M Kita
Journal:  Osteoporos Int       Date:  2011-11-26       Impact factor: 4.507

4.  Calcium rather than cyclic AMP is an intracellular messenger of parathyroid hormone action on glycogen metabolism in isolated rat hepatocytes.

Authors:  T Mine; I Kojima; E Ogata
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

5.  Osteoporosis: a bone turnover defect resulting from an elevated parathyroid hormone concentration within the bone-marrow cavity?

Authors:  M J Atkinson; T Schettler; H Bodenstein; R D Hesch
Journal:  Klin Wochenschr       Date:  1984-02-01

6.  Factors that influence parathyroid hormone half-life: determining if new intraoperative criteria are needed.

Authors:  Andrew J Leiker; Tina W F Yen; Dan C Eastwood; Kara M Doffek; Aniko Szabo; Douglas B Evans; Tracy S Wang
Journal:  JAMA Surg       Date:  2013-07       Impact factor: 14.766

7.  Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients.

Authors:  R D Hesch; U Busch; M Prokop; G Delling; E F Rittinghaus
Journal:  Calcif Tissue Int       Date:  1989-03       Impact factor: 4.333

8.  The path to the standardization of PTH: Is this a realistic possibility? a position paper of the IFCC C-BM.

Authors:  Etienne Cavalier; Samuel Vasikaran; Harjit P Bhattoa; Annemieke C Heijboer; Konstantinos Makris; Candice Z Ulmer
Journal:  Clin Chim Acta       Date:  2021-01-04       Impact factor: 3.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.